NCT05103098 is a NA clinical trial of misoprostol 400 mcg in Miscarriage, sponsored by hany farouk.

Who is sponsoring NCT05103098?

NCT05103098 is sponsored by hany farouk.

What drugs are being tested in NCT05103098?

Interventions in NCT05103098: misoprostol 400 mcg, misoprostol 800 mcg.

What condition does NCT05103098 study?

NCT05103098 studies Miscarriage.

Is NCT05103098 still recruiting?

NCT05103098 is currently status unknown. Last updated 2 November 2021.

Last reviewed 2021-11-02 · How we verify

NCT05103098

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sublingual Misoprostol In Medical Treatment of First Trimester Missed Miscarriage

Status unknown NA Last updated 2 November 2021

What this trial tests

NA trial testing misoprostol 400 mcg in Miscarriage in 200 participants. Status unknown.

Timeline

1 November 2021

Primary endpoint
31 December 2022

31 March 2023

Quick facts

Lead sponsor	hany farouk
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	200
Start date	1 November 2021
Primary completion	31 December 2022
Estimated completion	31 March 2023
Sites	1 location across Egypt

Drugs / interventions tested

misoprostol 400 mcg — full drug profile →
misoprostol 800 mcg — full drug profile →

Conditions studied

Miscarriage — all drugs for Miscarriage →

Sponsor

hany farouk — full company profile →

Who can join

Adults 18 to 40, female only, with Miscarriage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this work is to compare the effectiveness of sublingual misoprostol 400 mcg versus 800 mcg for medical treatment of the first trimester missed miscarriage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Miscarriage

Currently open trials in the same condition.

NCT07109947 — Use of Aromatase Inhibitor Before Misoprostol in Medical Termination of Miscarriage · NA · recruiting
NCT06576622 — PERIodontal Disease, Microbiota and Miscarriage · recruiting
NCT06862089 — A Prospective Study Evaluating the Impact of Conservative Management on Retained Products of Conception and EMV · recruiting
NCT06452719 — Letrozole and Misoprostol for Early Pregnancy Loss Management · Phase 2 · recruiting
NCT05725512 — Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages · Phase 4 · recruiting

Other hany farouk trials

Trials by the same sponsor.

NCT05094375 — Vaginal Misoprostol In Medical Treatment of First Trimester Missed Miscarriage · NA · unknown
NCT03777696 — Buccal Misoprostol and Intravenous Tranexamic Acid During Emergent Cesarean Delivery · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05103098 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by hany farouk
Last refreshed: 2 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05103098.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing